Implementing a Nurse-Enabled, Shared-Care Model to Address Unmet Needs of People with Neuroendocrine Tumours
- Conditions
- euroendocrine NeoplasmsNeuroendocrine NeoplasmsCancer - Neuroendocrine tumour (NET)Public Health - Health service research
- Registration Number
- ACTRN12623000829617
- Lead Sponsor
- Caring Futures Institute, College of Nursing and Health Sciences, Flinders University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 510
Patients aged 18 years of age or older
- histologically confirmed neuroendocrine neoplasm (NENs) as per the 2017 World Health Organisation Classification:
oWell differentiated neuroendocrine neoplasms: Neuroendocrine tumours (NET) (Grades 1-3)
oPoorly differentiated neuroendocrine neoplasms: Neuroendocrine carcinoma (NEC)
- can identify, or be willing to identify a usual General Practitioner or General Practice
- ambulatory with ECOG performance status of 0-2
- have access to a telephone or telehealth via smartphone, electronic tablet, personal computer, or equivalent, and
- be able to speak and read English.
- Patients diagnosed with pheochromocytoma or paraganglioma
- Patients with small cell lung NEC or large cell lung NEC
- Patients with severe mental, cognitive, or physical conditions or other circumstance that would limit their ability to participate at the discretion of the treating clinician
- Patients judged to have <6 months of life expectancy at the discretion of the treating clinician
- Patients judged to be unable to provide consent at the discretion of the treating clinician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Health-related Quality of Life - measured via the EORTC QLQ-C30[ Baseline, 6 months post-baseline, 12 months post-baseline.]
- Secondary Outcome Measures
Name Time Method